Relying on a recent Connecticut Supreme Court interpretation of the Connecticut Product Liability Act, the U.S. Court of Appeals for the Second Circuit vacated the dismissal of a product liability complaint over Bausch & Lomb’s Trulign lenses, finding the claim is not preempted by the federal Food, Drug, and Cosmetic Act.

After having a Trulign Toric intraocular lens implanted in each eye, complainant Marjorie Glover experienced significant vision loss and was diagnosed with Z syndrome, a postoperative complication in which part of the lens moves forward toward the surface of the eye and another part stays in place or moves backward, creating a Z-shaped astigmatism, according to court documents.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]